
NASDAQ:CDK • US12508E1010
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CDK Global Inc (CDK).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-12-16 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-08-18 | Morgan Stanley | Maintains | Overweight |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.915B -15.77% | 1.96B 2.37% | 1.673B -14.64% | 1.819B 8.70% | 1.904B 4.69% | 2.015B 5.84% | 2.1B 4.22% | 2.211B 5.26% | |
| EBITDA YoY % growth | 713.5M -0.65% | 674.2M -5.51% | 536M -20.50% | 677.306M 26.36% | 727.2M 7.37% | 773.334M 6.34% | 818.166M 5.80% | 874.254M 6.86% | |
| EBIT YoY % growth | 623.7M -2.41% | 574.6M -7.87% | 437.3M -23.89% | 484.967M 10.90% | 515.273M 6.25% | 592.725M 15.03% | 649.298M 9.54% | 718.385M 10.64% | |
| Operating Margin | 32.57% | 29.31% | 26.14% | 26.67% | 27.06% | 29.41% | 30.92% | 32.50% | |
| EPS YoY % growth | 3.73 14.07% | 3.18 -14.75% | 2.76 -13.21% | 2.96 7.22% | 3.26 10.24% | 3.69 13.00% | 4.07 10.52% | 4.55 11.62% |
| Q4 / 22 | Q1 / 23 | Q2 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.80 20.89% | 0.76 -1.62% | 0.77 3.73% |
| Revenue Q2Q % growth | 464.223M 10.50% | 476.51M 8.30% | 485.226M 11.11% |
| EBITDA Q2Q % growth | 181.656M -9.35% | 179.18M 25.04% | 181.243M 8.79% |
| EBIT Q2Q % growth | 127.661M 25.53% | 123.893M 7.08% | 123.733M 14.89% |
6 analysts have analysed CDK and the average price target is 58.65 null. This implies a price increase of 7.1% is expected in the next year compared to the current price of 54.76.
CDK Global Inc (CDK) will report earnings on 2022-08-15.
The consensus EPS estimate for the next earnings of CDK Global Inc (CDK) is 0.8 null and the consensus revenue estimate is 464.22M null.
The consensus rating for CDK Global Inc (CDK) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.